Detalhe da pesquisa
1.
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.
Nat Med
; 29(4): 869-879, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37069359
2.
Previous therapy with immune checkpoint inhibitor as a cause of hypothyroidism, myositis, and renal insufficiency in a candidate for allogeneic hematopoietic transplantation.
Transpl Immunol
; 75: 101705, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055435